中文名 | N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯 |
英文名 | ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate |
别名 | 苯乙酰甘氨酸乙酯 N-(1-(苯基乙酰基) --脯氨酚 N-(1-(苯基乙酰基)-L-脯氨酰)甘氨 N-(1-苯基乙酰基)-L-脯氨酰胺甘氨酸乙酯 N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯 NOOPEPTN-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯 N-(1-(苯基乙酰基)-L-脯氨酰) 甘氨酸乙酯 157115-85-0 |
英文别名 | Noopept GVS 111 SGS 111 GVS-111 noopept powder Nootropic GVS-111 ethyl phenylacetyl-Pro-Gly Ethyl 1-(phenylacetyl)-L-prolylglycinate ethyl 1-(phenylacetyl)-L-prolylglycinate N-(1-(Phenylacetyl)-L-prolyl)glycineethylester N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester Glycine, N-(1-(phenylacetyl)-L-prolyl)-, ethyl ester (S)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxaMido)acetate ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate |
CAS | 157115-85-0 |
EINECS | 1592732-453-0 |
化学式 | C17H22N2O4 |
分子量 | 318.37 |
InChI | InChI=1/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1 |
密度 | 1.202±0.06 g/cm3(Predicted) |
熔点 | 94.0 to 98.0 °C |
沸点 | 547.3±50.0 °C(Predicted) |
闪点 | 284.8°C |
蒸汽压 | 4.93E-12mmHg at 25°C |
溶解度 | 溶于DMSO (高达25 mg/ml) |
折射率 | 1.548 |
酸度系数 | 13.41±0.20(Predicted) |
存储条件 | -20°C |
稳定性 | 从提供的购买之日起稳定1年。DMSO中的溶液可以在-20 °C下储存长达2个月。 |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | Nooglutil exhibits pharmacologically significant competition with a selective agonist of AMPA receptors ([G-3H]Ro 48-8587) for the receptor binding sites (with IC50 = 6.4 +/- 0.2 microM), while the competition of noopept for these receptor binding sites was lower by an order of magnitude (IC50 = 80 +/- 5.6 microM) [1]. GVS-111 significantly increased neuronal survival after H(2)O(2)-treatment displaying a dose-dependent neuroprotective activity from 10 nM to 100 microM, and an IC(50) value of 1.21+/-0.07 microM. GVS-111 inhibited the accumulation of intracellular free radicals and lipid peroxidation damage in neurons treated with H(2)O(2) or FeSO(4), suggesting an antioxidant mechanism of action [2]. |
体内研究 | N-Phenylacetyl-L-prolylglycine ethyl ester (GVS-111) administered intravenously at a dose of 0.5 mg/kg/day, for the first time 1 h after ischaemic lesion and then for 9 post-operative days, with the last administration 15 min before testing, attenuated the deficit [3]. GVS-111 itself was not found in rat brain 1 h after 5 mg/kg i.p. administration up to limit of detection (LOD) under high performance liquid chromatography (HPLC) conditions [4]. The most pronounced antiinflammatory effect of dipeptide was observed on the model of adjuvant arthritis in rats, where the drug administered over 25 days in a daily dose of 0.5 mg/kg (i.m.) or 5 mg/kg (p.o.) significantly reduced the chronic immune inflammation (on the 12th day, by 94.0 and 74.1%, respectively) [5]. |
RTECS | MC0814400 |
海关编号 | 29339900 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.141 ml | 15.705 ml | 31.41 ml |
5 mM | 0.628 ml | 3.141 ml | 6.282 ml |
10 mM | 0.314 ml | 1.57 ml | 3.141 ml |
5 mM | 0.063 ml | 0.314 ml | 0.628 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!